2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Generalized Pustular Psoriasis: new trials by email Literature Review of Generalized Pustular Psoriasis trials Research Report on Generalized Pustular Psoriasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated Flares Spesolimab - Generalized Pustular Psoriasis | Phase 4 | Completed | LEO Pharma | 42 | 2023-10-22 | 2026-10-26 |
| A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis Ixekizumab - Generalized Pustular Psoriasis, Erythrodermic Psoriasis | Phase 4 | Completed | Eli Lilly and Company | 12 | 2019-07-05 | 2021-08-13 |
Psoriasis (2)
Skin Diseases (2) · Skin Diseases, Papulosquamous (2) · Skin and Connective Tissue Diseases (2)
ixekizumab (1) · spesolimab (1)
Eli Lilly and Company (1) · LEO Pharma (1)
Australia (1) · Belgium (1) · Brazil (1) · China (1) · France (1) · Germany (1) · India (1) · Italy (1) · Japan (1) · Malaysia (1) · Singapore (1) · South Africa (1) · South Korea (1) · Spain (1) · Taiwan (1)